1-2 of 2
Jingrui Sui
Close
Sort by
Journal Articles

Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura

Ruinan Lu, Jingrui Sui, X. Long Zheng
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5378–5388.
https://doi.org/10.1182/bloodadvances.2020003065
Published: 2020
Includes: Supplemental data
Journal Articles

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Jingrui Sui, Wenjing Cao, Konstantine Halkidis, Mohammad S. Abdelgawwad, Nicole K. Kocher, Bryan Guillory, Lance A. Williams, Radhika Gangaraju, Marisa B. Marques, X. Long Zheng
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4177–4186.
https://doi.org/10.1182/bloodadvances.2019000939
Published: 2019
Includes: Supplemental data